SEC Filings

Filing date	Description	Form	View
Dec 15, 2006	REGDEX/A	REGDEX/A	View HTML
Jul 21, 2006	REGDEX	REGDEX	View HTML

Data provided by Kaleidoscope.

For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE

SEC Filings

SEC Filings

Overview

Events and Presentations

Press Releases

SEC Filings

Stock Information

Management

Corporate Governance

Investor FAQs

Email Alerts

3,4,5
Annual Filings
Current Reports
Mergers & Acquisitions
Other
Proxy Filings
Quarterly Filings
Registration Statements